Sunovion Growth Study Pediatric Subjects With Mild Asthma & Allergic Rhinitis

PHASE4CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
AsthmaAllergic Rhinitis
Interventions
DRUG

Alvesco/Omnaris, QVAR/Beconase, Placebo/Placebo

Alvesco Inhalation Aerosol 80 BID and Omnaris Nasal Spray 200 mcg QD QVAR Inhalation Aerosol 40 mcg BID and Beconase AQ Nasal Spray 168 mcg BID Placebo Nasal Spray QD/Placebo Inhalation Aerosol BID

DRUG

Alvesco/Omnaris, Placebo/Placebo, QVAR/Beconase

Alvesco Inhalation Aerosol 80 BID and Omnaris Nasal Spray 200 mcg QD, Placebo Nasal Spray QD and Placebo Inhalation Aerosol BID, QVAR Inhalation Aerosol 40 mcg BID and Beconase AQ Nasal Spray 168 mcg BID

DRUG

QVAR/Beconase, Alvesco/Omnaris, Placebo/Placebo

QVAR Inhalation Aerosol 40 mcg BID and Beconase AQ Nasal Spray 168 mcg BID, Alvesco Inhalation Aerosol 80 BID and Omnaris Nasal Spray 200 mcg QD, Placebo Nasal Spray QD/Placebo Inhalation Aerosol BID

DRUG

QVAR/Beconase, Placebo/Placebo, Alvesco/Omnaris

QVAR Inhalation Aerosol 40 mcg BID and Beconase AQ Nasal Spray 168 mcg BID, Placebo Nasal Spray QD and Placebo Inhalation Aerosol BID, Alvesco Inhalation Aerosol 80 BID and Omnaris Nasal Spray 200 mcg QD

DRUG

Placebo/Placebo, Alvesco/Omnaris, QVAR/Beconase

Placebo Nasal Spray QD and Placebo Inhalation Aerosol BID, Alvesco Inhalation Aerosol 80 BID and Omnaris Nasal Spray 200 mcg QD, QVAR Inhalation Aerosol 40 mcg BID and Beconase AQ Nasal Spray 168 mcg BID

DRUG

Placebo/Placebo, QVAR/Beconase, Alvesco/Omnaris

Placebo Nasal Spray QD and Placebo Inhalation Aerosol BID, QVAR Inhalation Aerosol 40 mcg BID and Beconase AQ Nasal Spray 168 mcg BID, Alvesco Inhalation Aerosol 80 BID and Omnaris Nasal Spray 200 mcg QD

Trial Locations (2)

15212

Alleghney General Hospital, Pittsburgh

15220

Pediatric Alliance-Greentree Division, Green Tree

All Listed Sponsors
lead

West Penn Allegheny Health System

OTHER

NCT01550471 - Sunovion Growth Study Pediatric Subjects With Mild Asthma & Allergic Rhinitis | Biotech Hunter | Biotech Hunter